Better Choice Company announced the acquisition of all the issued and outstanding common shares of Aimia Pet Healthco. Better Choice will now be in a position to manage the clinical trials internally in hopes to develop a supplement to support weight loss in domestic animals. More than half of all dogs and cats worldwide are classified as overweight or obese and can suffer from the same weight-related health complications as humans – including arthritis, diabetes, and high blood pressure. Following the successful creation by Pfizer of its Slentrol medication, Better Choice will work with Aimia to develop treats and toppers to safely combat pet obesity. The goal of the research and development work is to mirror the weight loss benefits of leading brands for domestic animals and in humans including Slentrol, Wegovy, Ozempic, and Mounjaro with added protein and nutrients from the Company’s halo products to promote lean muscle and overall pet health.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
